The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

Journal of Experimental Medicine

Volumn 206, Issue 7, 2009, Pages 1495-1503

  Brandt, Cameron S ^a   Baratin, Myriam ^b,c,d   Yi, Eugene C ^a   Kennedy, Jacob ^a   Gao, Zeren ^a   Fox, Brian ^a   Haldeman, Betty ^a   Ostrander, Craig D ^a   Kaifu, Tomonori ^b,c,d   Chabannon, Christian ^c,e   Moretta, Alessandro ^f   West, Robert ^a   Xu, WenFeng ^a   Vivier, Eric ^b,c,d,g   Levin, Steven D ^a  

^a ZYMOGENETICS INC   (United States)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^c INSERM   (France)

^d CNRS   (France)

^e INSTITUT PAOLI CALMETTES   (France)

^f UNIVERSITY OF GENOA   (Italy)

^g HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; B7 H6 ANTIGEN; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKP30; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ARTICLE; CELL ACTIVATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; MOUSE; MULTIGENE FAMILY; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, SURFACE; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN FC FRAGMENTS; K562 CELLS; KILLER CELLS, NATURAL; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; RECOMBINANT FUSION PROTEINS;

EID: 67650507057     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20090681     Document Type: Article

References (31)

1. Arnon, T.I., H. Achdout, O. Levi, G. Markel, N. Saleh, G. Katz, R. Gazit, T. Gonen-Gross, J. Hanna, E. Nahari, et al. 2005. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat. Immunol. 6:515-523.
2. Bottino, C., R. Castriconi, L. Moretta, and A. Moretta. 2005. Cellular ligands of activating NK receptors. Trends Immunol. 26:221-226.
3. Bryceson, Y.T., M.E. March, H.G. Ljunggren, and E.O. Long. 2006. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 214:73-91.
4. Byrd, A., S.C. Hoffmann, M. Jarahian, F. Momburg, and C. Watzl. 2007. Expression analysis of the ligands for the natural killer cell receptors NKp30 and NKp44. PLoS One. 2:e1339.
5. Castriconi, R., A. Dondero, R. Augugliaro, C. Cantoni, B. Carnemolla, A.R. Sementa, F. Negri, R. Conte, M.V. Corrias, L. Moretta, et al. 2004. Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis. Proc. Natl. Acad. Sci. USA. 101:12640-12645.
6. Duncan, A.R., and G. Winter. 1988. The binding site for C1q on IgG. Nature. 332:738-740.
7. Duncan, A.R., J.M. Woof, L.J. Partridge, D.R. Burton, and G. Winter. 1988. Localization of the binding site for the human high-affinity Fc receptor on IgG. Nature. 332:563-564.
8. Ferlazzo, G., M.L. Tsang, L. Moretta, G. Melioli, R.M. Steinman, and C. Munz. 2002. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195:343-351.
9. Hecht, M.L., B. Rosental, T. Horlacher, O. Hershkovitz, J.L. De Paz, C. Noti, S. Schauer, A. Porgador, and P.H. Seeberger. 2009. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences. J. Proteome Res. 8:712-720.
10. Kärre, K., H.G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature. 319:675-678.
11. Lanier, L.L. 2005. NK cell recognition. Annu. Rev. Immunol. 23:225-274.
12. Lichtenfels, R., W.E. Biddison, H. Schulz, A.B. Vogt, and R. Martin. 1994. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J. Immunol. Methods. 172:227-239.
13. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M.C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197-223.
14. Nowbakht, P., M.C. Ionescu, A. Rohner, C.P. Kalberer, E. Rossy, L. Mori, D. Cosman, G. De Libero, and A. Wodnar-Filipowicz. 2005. Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias. Blood. 105:3615-3622.
15. Parham, P. 2005. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5:201-214.
16. Pende, D., S. Parolini, A. Pessino, S. Sivori, R. Augugliaro, L. Morelli, E. Marcenaro, L. Accame, A. Malaspina, R. Biassoni, et al. 1999. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 190:1505-1516.
17. Pende, D., P. Rivera, S. Marcenaro, C.C. Chang, R. Biassoni, R. Conte, M. Kubin, D. Cosman, S. Ferrone, L. Moretta, and A. Moretta. 2002. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res. 62:6178-6186.
18. Pogge von Strandmann, E., V.R. Simhadri, B. Von Tresckow, S. Sasse, K.S. Reiners, H.P. Hansen, A. Rothe, B. Boll, V.L. Simhadri, P. Borchmann, et al. 2007. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity. 27:965-974.
19. Raulet, D.H. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3:781-790.
20. Schleinitz, N., C. Cognet, S. Guia, F. Laugier-Anfossi, M. Baratin, J. Pouget, J.F. Pelissier, J.R. Harle, E. Vivier, and D. Figarella-Branger. 2008. Expression of the CD85j (leukocyte Ig-like receptor 1, Ig-like transcript 2) receptor for class I major histocompatibility complex molecules in idiopathic inflammatory myopathies. Arthritis Rheum. 58:3216-3223.
21. Shyamsundar, R., Y.H. Kim, J.P. Higgins, K. Montgomery, M. Jorden, A. Sethuraman, M. Van De Rijn, D. Botstein, P.O. Brown, and J.R. Pollack. 2005. A DNA microarray survey of gene expression in normal human tissues. Genome Biol. 6:R22.
22. Simhadri, V.R., K.S. Reiners, H.P. Hansen, D. Topolar, V.L. Simhadri, K. Nohroudi, T.A. Kufer, A. Engert, and E. Pogge Von Strandmann. 2008. Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function. PLoS One. 3:e3377.
23. Sivori, S., S. Parolini, E. Marcenaro, R. Castriconi, D. Pende, R. Millo, and A. Moretta. 2000. Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines. J. Neuroimmunol. 107:220-225.
24. Smyth, M.J., Y. Hayakawa, K. Takeda, and H. Yagita. 2002. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat. Rev. Cancer. 2:850-861.
25. Soriani, A., A. Zingoni, C. Cerboni, M.L. Iannitto, M.R. Ricciardi, V. Di Gialleonardo, M. Cippitelli, C. Fionda, M.T. Petrucci, A. Guarini, et al. 2009. ATM-ATR dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK cell susceptibility and is associated with a senescent phenotype. Blood. 113:3503-3511.
26. Sundblad, G., S. Holojda, L. Roux, A. Varki, and H.H. Freeze. 1988. Sulfated N-linked oligosaccharides in mammalian cells. II. Identification of glycosaminoglycan-like chains attached to complex-type glycans. J. Biol. Chem. 263:8890-8896.
27. Vitale, M., M. Della Chiesa, S. Carlomagno, D. Pende, M. Arico, L. Moretta, and A. Moretta. 2005. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood. 106:566-571.
28. Vivier, E., E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini. 2008. Functions of natural killer cells. Nat. Immunol. 9:503-510.
29. Yokoyama, W.M. 2008. Mistaken notions about natural killer cells. Nat. Immunol. 9:481-485.
30. Zheng, X.X., A.W. Steele, W.W. Hancock, K. Kawamoto, X.C. Li, P.W. Nickerson, Y. Li, Y. Tian, and T.B. Strom. 1999. IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice. J. Immunol. 163:4041-4048.
31. Zou, W., and L. Chen. 2008. Inhibitory B7-family molecules in the tumour microenvironment. Nat. Rev. Immunol. 8:467-477.